Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy

Do Children Have the Same Vulnerability to Metabolic Drug-Drug Interactions as Adults? A Critical Analysis of the Literature

(2013) Farzaneh Salem et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Influence of CYP2C19 Polymorphism and Concomitant Antiepileptic Drugs on Serum Clobazam and N-Desmethyl Clobazam Concentrations in Patients With Epilepsy

(2013) Yoshiaki Yamamoto et al.   THERAPEUTIC DRUG MONITORING

Clobazam Therapeutic Drug Monitoring

(2013) Jose de Leon et al.   THERAPEUTIC DRUG MONITORING

Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy

(2013) Junji Saruwatari et al.   THERAPEUTIC DRUG MONITORING

Influence of Concomitant Antiepileptic Drugs on Plasma Lamotrigine Concentration in Adult Japanese Epilepsy Patients

(2012) Yoshiaki Yamamoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Pharmacokinetic Drug Interactions Between Clobazam and Drugs Metabolized by Cytochrome P450 Isoenzymes

(2012) Mark Walzer et al.   PHARMACOTHERAPY

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

(2011) Y. T. Ng et al.   NEUROLOGY

Antiepileptic Drug Interactions - Principles and Clinical Implications

(2010) Svein I. Johannessen et al.   Current Neuropharmacology

Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

(2008) Philip N. Patsalos et al.   EPILEPSIA